**Core Concept**
Listeria monocytogenes is a gram-positive, facultative intracellular pathogen that can invade host cells and evade the host immune response. The ability of Listeria to resist phagocytosis is a critical virulence factor that allows it to survive and replicate within host cells. This resistance is primarily due to the action of a specific bacterial protein.

**Why the Correct Answer is Right**
Listeria resists phagocytosis by producing the protein listeriolysin O (LLO), a pore-forming toxin that disrupts the phagosomal membrane. LLO is secreted by Listeria into the phagosome, where it creates pores in the membrane, allowing the bacterium to escape from the phagosome and gain access to the cytosol. This process is facilitated by the phospholipase C activity of LLO, which disrupts the phospholipid bilayer of the phagosomal membrane.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify the mechanism by which Listeria resists phagocytosis. While some bacteria may resist phagocytosis through other mechanisms, Listeria's resistance is specifically due to the action of listeriolysin O.

**Option B:** This option is incorrect because it refers to a different bacterial toxin that is not responsible for Listeria's resistance to phagocytosis. Other bacterial toxins, such as alpha-toxin from Staphylococcus aureus, may have similar pore-forming activity, but they are not relevant to Listeria's virulence.

**Option C:** This option is incorrect because it does not accurately describe the mechanism by which Listeria resists phagocytosis. While some bacteria may use autophagy to survive within host cells, Listeria's resistance is specifically due to the action of listeriolysin O.

**Clinical Pearl / High-Yield Fact**
Listeriolysin O is a critical virulence factor for Listeria monocytogenes, and its activity is essential for the bacterium's ability to invade host cells and cause disease. Understanding the mechanism by which Listeria resists phagocytosis is essential for the development of effective therapeutic strategies against this pathogen.

**Correct Answer: C.**